What changed from existing technology?
This study found that a substance from a type of plant called Salvia oligophylla can kill breast cancer cells by causing them to undergo a process called apoptosis, which is a form of programmed cell death.
This is the first study to identify and characterize the apoptosis-inducing activity of an abietane diterpenoid-rich fraction from Salvia oligophylla roots against MCF-7 cancer cells.
Commercialization signals visible at publication
This is not a success probability or investment opinion. It prioritizes follow-up using evidence available when the paper was published.
Verified evidence · 1
ophylla Aucher ex Benth., an endemic Iranian species, remains largely unexplored with respect to its phytochemical composition and biological activities.
Abstract ↗- 시제품·장치 구현 근거 미확인
- 제조·규모 확장 근거 미확인
- 장기·실사용 검증 근거 미확인
Later patent, company, clinical, and production events are added separately only after verification.
Patent check: Not checked yetCurrent technology stage: Validation stage
See what changed before reading the full paper.
What still needs to be solved?
Repeated real-world validation, manufacturability, cost, and long-term stability still require follow-up evidence.
What could change if this succeeds?
This fraction may have potential as a natural compound for developing therapies targeting apoptosis in breast cancer treatment.
Keep following this technology
Revisit changes when new papers, patents, company participation, validation, or products appear.